Cashu
Castle Biosciences Advances Melanoma Diagnostics with DecisionDx-Melanoma at AAD Annual Meeting
5 days ago
Stocks
Health Care
cstl
Castle Biosciences
NASDAQ: CSTL
-0.21 (-0.84%)
24.84
USD
At close at Apr 03, 20:40 UTC
Latest Castle Biosciences News
prnewswire.com
Castle Biosciences' DecisionDx-Melanoma Test Significantly Improves Risk Prediction Within AJCC Stages to Support Personalized, Risk-Aligned Management of Cutaneous Melanoma, Data to Be Presented at AAD 2026
9 days ago
benzinga.com
Expert Outlook: Castle Biosciences Through The Eyes Of 6 Analysts
about 1 month ago
benzinga.com
Castle Biosciences Q4 Earnings Assessment
about 1 month ago
benzinga.com
Earnings Scheduled For February 26, 2026
about 1 month ago
benzinga.com
Exploring Castle Biosciences's Earnings Expectations
about 1 month ago
benzinga.com
Why Castle Biosciences' Rally Might Just Be Getting Started
5 months ago
benzinga.com
Earnings Scheduled For November 3, 2025
5 months ago
benzinga.com
A Glimpse of Castle Biosciences's Earnings Potential
5 months ago
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
8 months ago
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
8 months ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.